AL
Bluelinea S.A.
ALBLU.PA · PAR
0.16 € +0.63% (+0.00 €)
1M -9.14%
Market Cap 2.39M €
P/E Ratio -
Div. Yield -
ROE 93.65%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.23x
P/B 0.84x
EV/EBITDA 6.23x
Growth
16 /100
Declining Book val. growth 12.76%
Rev. growth 0.04%
FCF growth N/A
Profitability
20 /100
Weak Net margin 14.49%
Op. margin 12.55%
FCF margin 16.73%
Quality
14 /100
Poor ROE 93.65%
ROA 16.31%
Asset turnover 1.13x
Debt
30 /100
High Current ratio 0.74x
Int. coverage -12.12x
Net debt/EBITDA 3.19x
Stability
35 /100
Moderate Rev. volatility 8.55%
EPS volatility 57,711.40%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALBLU.PA
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Laurent Levasseur
Employees
89
Headquarters
Versailles